CD8+T-话题@MedSci

#CD8+T#

3篇内容 | 2033人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2226661, encodeId=9963222666111, content=<a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a> <a href='/topic/show?id=8fe4828097b' target=_blank style='color:#2F92EE;'>#肿瘤免疫#</a> <a href='/topic/show?id=fe74436549' target=_blank style='color:#2F92EE;'>#CD8+T#</a> <a href='/topic/show?id=1ab41192e693' target=_blank style='color:#2F92EE;'>#免疫检查点配体#</a>, objectTitle=盘点免疫检查点的配体, objectType=article, longId=776801, objectId=bbd8e7680146, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720686653308_5579292.png, objectUrl=/article/show_article.do?id=bbd8e7680146, replyNumber=0, likeNumber=0, createdTime=2024-09-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bbd8e7680146, moduleTitle=盘点免疫检查点的配体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbd8e7680146)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1051118, encodeId=fbc1105111870, content=<a href='/topic/show?id=fe74436549' target=_blank style='color:#2F92EE;'>#CD8+T#</a>, objectTitle=Nat Commun：循环CD8+T细胞的染色质可及性预测胃癌患者对抗PD-1疗法的应答, objectType=article, longId=207306, objectId=d12f20e30662, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021218/1613662706622_2467676.PNG, objectUrl=/article/show_article.do?id=d12f20e30662, replyNumber=0, likeNumber=99, createdTime=2021-09-14, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12f20e30662, moduleTitle=Nat Commun：循环CD8+T细胞的染色质可及性预测胃癌患者对抗PD-1疗法的应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d12f20e30662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1051117, encodeId=c03f105111e3c, content=<a href='/topic/show?id=fe74436549' target=_blank style='color:#2F92EE;'>#CD8+T#</a>, objectTitle=Nat Immunol ：抑制MEK可将CD8+T细胞重编程为抗肿瘤型记忆干细胞, objectType=article, longId=203915, objectId=7c2b203915cd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/504.jpg, objectUrl=/article/show_article.do?id=7c2b203915cd, replyNumber=0, likeNumber=101, createdTime=2021-09-14, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c2b203915cd, moduleTitle=Nat Immunol ：抑制MEK可将CD8+T细胞重编程为抗肿瘤型记忆干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c2b203915cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1051116, encodeId=332310511163f, content=<a href='/topic/show?id=fe74436549' target=_blank style='color:#2F92EE;'>#CD8+T#</a>, objectTitle=J Gastroenterology: CCL19可以增强CD8+T细胞反应并加速 HBV 清除, objectType=article, longId=214269, objectId=0d2321426943, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021715/1626316696363_2071404.jpg, objectUrl=/article/show_article.do?id=0d2321426943, replyNumber=0, likeNumber=112, createdTime=2021-09-14, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d2321426943, moduleTitle=J Gastroenterology: CCL19可以增强CD8+T细胞反应并加速 HBV 清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d2321426943)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CD8+T

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#免疫治疗# #肿瘤免疫# #CD8+T# #免疫检查点配体#

盘点免疫检查点的配体

2024-09-19发表于上海

病毒猎手 (审核中...)

前往app查看评论内容

#CD8+T#

Nat Commun：循环CD8+T细胞的染色质可及性预测胃癌患者对抗PD-1疗法的应答

2021-09-14

病毒猎手 (审核中...)

前往app查看评论内容

#CD8+T#

Nat Immunol ：抑制MEK可将CD8+T细胞重编程为抗肿瘤型记忆干细胞

2021-09-14

病毒猎手 (审核中...)

前往app查看评论内容

#CD8+T#

J Gastroenterology: CCL19可以增强CD8+T细胞反应并加速 HBV 清除

2021-09-14

科室
- - 订阅+
  - 更多科室
工具
服务